Document is current
Any future updates will be listed below
-
Authors
Yau, Kevin http://orcid.org/0000-0001-8653-6778
Kuah, Rachel http://orcid.org/0009-0003-3931-0567
Cherney, David Z. I. http://orcid.org/0000-0003-4164-0429
Lam, Tony K. T. http://orcid.org/0000-0003-2908-3324
- License Information
-
More Information
Article History
Accepted: 2 January 2024
First Online: 13 February 2024
Competing interests
: D.Z.I.C. has received consulting fees or speaking honoraria or both from Janssen, Bayer, Boehringer Ingelheim-Eli, Lilly, AstraZeneca, Merck & Co Inc, Prometic and Sanofi, and has received operating funds from Janssen, Boehringer Ingelheim-Eli, Lilly, Sanofi, AstraZeneca and Merck & Co Inc. The other authors declare no competing interests.